After WHO nod, US allows travellers with Covaxin shot from Nov 8

After WHO nod to Covaxin, US has given green light to travellers fully vaccinated against Covid-19 with the Indian vaccine to enter the US from November 8.

Talking to ANI over updating the approved travel list for Covaxin, CDC press officer, Scott Pauley said, "CDC's travel guidance applies to FDA approved or authorized and WHO Emergency Use Listing vaccines and encompasses any new vaccines that may be added to either of those lists over time."

The last-minute addition comes less than one week before the US launches its new travel system, which grants entry to foreign travellers who have received a vaccine that has been approved for emergency use by the US Food and Drug Administration (FDA) or the WHO.

Also Read: WHO approves Indian vaccine, Covaxin

The US Centers for Disease Control on Wednesday acknowledged the World Health Organisation's (WHO) granting emergency use listing (EUL) to India's indigenous vaccine Covaxin, developed by Bharat Biotech.

The new US travel rules will also accept travellers fully vaccinated with Pfizer-BioNTech, Johnson & Johnson, Moderna, Oxford-AstraZeneca, Covishield, Sinopharm and Sinovac.